GlassScriptPhysician profile
Erin D Kreisel
NPI 1841557386
$2,333.47
in general payments reported to CMS, 2019-2025
11 companies · $1,341 in 2025
The $1,341 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2023: $605 · 2024: $179 · 2025: $1,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471 · Travel and Lodging: $637 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.33 |
| Travel and Lodging | $636.89 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,196.32 | 2021-2025 | Micra, Abre |
| Abbott Laboratories | $314.05 | 2023-2024 | Jeti, Pressurewire, Esprit |
| Abbvie INC. | $240.36 | 2025 | |
| Biosense Webster, INC. | $147.66 | 2024 | Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.53 | 2023 | Lifevest |
| Janssen Scientific Affairs, LLC | $107.84 | 2021 | |
| Novartis Pharmaceuticals Corporation | $52.45 | 2025 | |
| Amgen INC. | $38.33 | 2023-2025 | Repatha |
| Boston Scientific Corporation | $31.59 | 2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.16 | 2024-2025 | Jardiance |
| B. Braun Interventional Systems INC. | $29.18 | 2023 | Spectraline Syringe |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Kreisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.